03 September 2021: Clinical Research
Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015–2019
Xiaoxiao Li ACDEG , Fenfen Xiang C , Zixi Chen D , Tao Zhang B , Zhaowei Zhu BC , Mengzhe Zhang BF , Rong Wu DG* , Xiangdong Kang A*DOI: 10.12659/MSM.932093
Med Sci Monit 2021; 27:e932093
Table 3 Changes of type-specific genital human papillomavirus detection across different age groups.
| HPV type | ≤24 years (n=164) | 25–34 years (n=498) | 35–44 years (n=252) | 45–54 years (n=132) | ≥55 years (n=181) | χ2 | P | gamma value |
|---|---|---|---|---|---|---|---|---|
| Any HPV | 116 (70.73%) | 315 (63.25%) | 148 (58.73%) | 93 (70.45%) | 132 (72.93%) | 1.748 | 0.186 | 0.033 |
| Low-risk | 105 (64.02%) | 267 (53.61%) | 125 (49.60%) | 85 (64.39%) | 124 (68.51%) | 4.711 | 0.030 | 0.062 |
| HPV-6 | 56 (34.15%) | 137 (27.51%) | 70 (27.78%) | 60 (45.45%) | 71 (39.23%) | 8.481 | 0.004 | 0.114 |
| HPV-11 | 53 (32.32%) | 112 (22.49%) | 45 (17.86%) | 22 (16.67%) | 52 (28.72%) | 0.672 | 0.412 | −0.075 |
| HPV-40 | 3 (1.83%) | 10 (2.01%) | 3 (1.19%) | 3 (2.27%) | 1 (0.55%) | 1.014 | 0.314 | −0.166 |
| HPV-42 | 1 (0.61%) | 7 (1.41%) | 3 (1.19%) | 3 (2.27%) | 2 (1.10%) | 0.219 | 0.640 | 0.103 |
| HPV-43 | 6 (3.66%) | 26 (5.22%) | 6 (2.38%) | 5 (3.79%) | 10 (5.52%) | 0.023 | 0.880 | −0.013 |
| HPV-44 | 5 (3.05%) | 9 (1.81%) | 1 (0.40%) | 3 (2.27%) | 8 (4.42%) | 1.242 | 0.265 | 0.083 |
| HPV-61 | 4 (2.44%) | 17 (3.41%) | 7 (2.78%) | 3 (2.27%) | 3 (1.66%) | 0.893 | 0.345 | −0.113 |
| HPV-81 | 3 (1.83%) | 13 (2.61%) | 3 (1.19%) | 5 (3.79%) | 4 (2.21%) | 0.058 | 0.810 | 0.020 |
| High-risk | 55 (33.54%) | 147 (29.52%) | 61 (24.21%) | 29 (21.97%) | 49 (27.07%) | 3.692 | 0.055 | −0.106 |
| HPV-16 | 16 (9.76%) | 35 (7.03%) | 9 (3.57%) | 4 (3.03%) | 5 (2.76%) | 11.555 | 0.001 | −0.342 |
| HPV-18 | 7 (4.27%) | 13 (2.61%) | 6 (2.38%) | 1 (0.76%) | 3 (1.66%) | 3.080 | 0.079 | −0.254 |
| HPV-26 | 0 (0.00%) | 3 (0.60%) | 1 (0.40%) | 0 (0.00%) | 0 (0.00%) | 0.589 | 0.443 | −0.271 |
| HPV-31 | 1 (0.61%) | 3 (0.60%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 2.458 | 0.117 | −0.699 |
| HPV-33 | 1 (0.61%) | 2 (0.40%) | 2 (0.79%) | 0 (0.00%) | 2 (1.10%) | 0.329 | 0.566 | 0.142 |
| HPV-35 | 2 (1.22%) | 5 (1.00%) | 4 (1.59%) | 1 (0.76%) | 6 (3.31%) | 2.833 | 0.092 | 0.254 |
| HPV-39 | 7 (4.27%) | 8 (1.61%) | 3 (1.19%) | 3 (2.27%) | 7 (3.87%) | 0.155 | 0.694 | −0.003 |
| HPV-45 | 2 (1.22%) | 5 (1.00%) | 1 (0.40%) | 2 (1.52%) | 2 (1.10%) | 0.003 | 0.954 | −0.021 |
| HPV-51 | 6 (3.66%) | 17 (3.41%) | 8 (3.17%) | 4 (3.03%) | 5 (2.76%) | 0.288 | 0.592 | −0.064 |
| HPV-52 | 9 (5.49%) | 20 (4.02%) | 6 (2.38%) | 5 (3.79%) | 2 (1.10%) | 4.896 | 0.027 | −0.268 |
| HPV-53 | 4 (2.44%) | 8 (1.61%) | 8 (3.17%) | 2 (1.52%) | 11 (6.08%) | 5.698 | 0.017 | 0.270 |
| HPV-55 | 0 (0.00%) | 8 (1.61%) | 2 (0.79%) | 2 (1.52%) | 3 (1.66%) | 0.710 | 0.399 | 0.161 |
| HPV-56 | 6 (3.66%) | 20 (4.02%) | 6 (2.38%) | 1 (0.76%) | 5 (2.76%) | 1.992 | 0.158 | −0.197 |
| HPV-58 | 5 (3.05%) | 15 (3.01%) | 6 (2.38%) | 4 (3.03%) | 3 (1.66%) | 0.733 | 0.392 | −0.110 |
| HPV-59 | 12 (7.32%) | 21 (4.22%) | 7 (2.78%) | 4 (3.03%) | 5 (2.76%) | 4.272 | 0.039 | −0.247 |
| HPV-66 | 11 (6.71%) | 12 (2.41%) | 5 (1.98%) | 1 (0.76%) | 5 (2.76%) | 3.678 | 0.055 | −0.286 |
| HPV-68 | 0 (0.00%) | 1 (0.20%) | 0 (0.00%) | 0 (0.00%) | 1 (0.55%) | 0.759 | 0.383 | 0.364 |
| HPV-82 | 5 (3.05%) | 5 (1.00%) | 2 (0.79%) | 2 (1.52%) | 2 (1.10%) | 0.882 | 0.348 | −0.204 |
| HPV-83 | 0 (0.00%) | 3 (0.60%) | 1 (0.40%) | 2 (1.52%) | 0 (0.00%) | 0.042 | 0.838 | 0.115 |
| HPV – human papillomavirus. | ||||||||